Vistagen Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
08/08
Vistagen <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Inc reports results for the quarter ended June 30 - Earnings Summary
  • Vistagen Therapeutics Inc VTGN.OQ reported a quarterly adjusted loss of 47 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -35 cents. The mean expectation of three analysts for the quarter was for a loss of 47 cents per share. Wall Street expected results to range from -49 cents to -44 cents per share.

  • Revenue rose 190.5% to $244.00 thousand from a year ago; analysts expected $650.00 thousand.

  • Vistagen Therapeutics Inc's reported EPS for the quarter was a loss of 47 cents​.

  • The company reported a quarterly loss of $15.1 million.

  • Vistagen Therapeutics Inc shares had risen by 48.5% this quarter and gained 0.7% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 6.4% in the last three months.​

  • In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is "buy."

  • Wall Street's median 12-month price target for Vistagen Therapeutics Inc is $12.00, about 77.3% above its last closing price of $2.73

This summary was machine generated from LSEG data August 8 at 04:21 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2025

-0.47

-0.47

Met

Mar. 31 2025

-0.50

-0.43

Beat

Dec. 31 2024

-0.51

-0.46

Beat

Sep. 30 2024

-0.39

-0.42

Missed

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10